BIODESIX, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIODESIX, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $6.46M.
- BIODESIX, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $16.67M.
- BIODESIX, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $4.62M.
- BIODESIX, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was -$15.00K, a 100.10% decline year-over-year.
- BIODESIX, INC. stock issued during period, value, new issues for fiscal 2025 was $6.78M, a 63.91% decline from fiscal 2024.
- BIODESIX, INC. stock issued during period, value, new issues for fiscal 2024 was $18.79M, a 32.90% decline from fiscal 2023.
- BIODESIX, INC. stock issued during period, value, new issues for fiscal 2023 was $28.00M, a 50.20% decline from fiscal 2022.
- BIODESIX, INC. stock issued during period, value, new issues for fiscal 2022 was $56.23M, a 258.66% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $6.46M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $16.67M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $6.78M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $4.62M 10-Q · filed 2025-11-03 | |
| 2024-12-31 | $18.79M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$15.00K 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $18.20M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $607.00K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $28.00M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $15.32M 10-Q · filed 2024-11-01 | |
| 2023-03-31 | -$61.00K 10-Q · filed 2024-11-01 | |
| 2022-12-31 | $56.23M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $1.75M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $14.33M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $1.42M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $15.68M 10-K · filed 2023-03-06 | |
| 2020-12-31 | $63.76M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |